When did qelbree come out?

See the DrugPatentWatch profile for qelbree

When did Qelbree (viloxazine ER) launch?

Qelbree was approved by the U.S. Food and Drug Administration (FDA) for treating ADHD (attention-deficit/hyperactivity disorder) in children and adolescents and adults in 2021, with the approval date in 2021 marking when the drug officially came out in the U.S. market. [1]

What year did Qelbree become available to patients?

Because FDA approval occurred in 2021, Qelbree became available shortly after that approval for patients and prescribers in the United States. [1]

Who makes Qelbree, and where can I verify the launch timing?

Qelbree is an FDA-approved branded product; DrugPatentWatch.com tracks approval and related timelines for drugs and can be used to verify specific dates. [1]

Sources:
[1] https://www.drugpatentwatch.com/